Ventyx Biosciences Inc
NASDAQ:VTYX
Cash Flow Statement
Cash Flow Statement
Ventyx Biosciences Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(77)
|
(83)
|
(84)
|
(106)
|
(73)
|
(91)
|
(108)
|
(125)
|
(158)
|
(181)
|
(193)
|
(193)
|
(171)
|
(153)
|
(135)
|
(124)
|
(119)
|
(107)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
(0)
|
(1)
|
|
| Stock-Based Compensation |
0
|
1
|
3
|
6
|
10
|
13
|
17
|
20
|
23
|
27
|
29
|
29
|
26
|
24
|
23
|
21
|
20
|
19
|
|
| Other Non-Cash Items |
59
|
55
|
41
|
45
|
10
|
13
|
15
|
16
|
17
|
19
|
20
|
21
|
18
|
15
|
15
|
13
|
14
|
15
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
2
|
4
|
10
|
10
|
12
|
(5)
|
(8)
|
(11)
|
(0)
|
6
|
(12)
|
(6)
|
(23)
|
(11)
|
1
|
(1)
|
4
|
|
| Cash from Operating Activities |
(17)
N/A
|
(26)
-55%
|
(39)
-50%
|
(51)
-33%
|
(53)
-4%
|
(66)
-24%
|
(99)
-49%
|
(117)
-18%
|
(151)
-29%
|
(162)
-7%
|
(167)
-3%
|
(183)
-10%
|
(158)
+14%
|
(159)
0%
|
(131)
+18%
|
(109)
+17%
|
(106)
+3%
|
(88)
+17%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
2
|
(71)
|
(214)
|
(231)
|
(214)
|
(77)
|
(75)
|
(77)
|
(60)
|
(86)
|
101
|
162
|
52
|
42
|
(15)
|
(31)
|
70
|
58
|
|
| Cash from Investing Activities |
2
N/A
|
(71)
N/A
|
(214)
-201%
|
(231)
-8%
|
(215)
+7%
|
(77)
+64%
|
(75)
+3%
|
(77)
-3%
|
(61)
+21%
|
(86)
-42%
|
101
N/A
|
162
+60%
|
51
-68%
|
42
-19%
|
(16)
N/A
|
(31)
-99%
|
70
N/A
|
58
-17%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
113
|
164
|
323
|
323
|
210
|
337
|
168
|
216
|
218
|
42
|
53
|
101
|
97
|
122
|
122
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
4
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
118
N/A
|
166
+41%
|
324
+95%
|
324
+0%
|
210
-35%
|
338
+61%
|
168
-50%
|
216
+29%
|
219
+1%
|
42
-81%
|
53
+26%
|
101
+89%
|
97
-3%
|
123
+26%
|
122
-1%
|
0
N/A
|
27
N/A
|
0
-99%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Net Change in Cash |
103
N/A
|
69
-33%
|
71
+2%
|
41
-41%
|
(57)
N/A
|
194
N/A
|
(6)
N/A
|
22
N/A
|
6
-71%
|
(206)
N/A
|
(12)
+94%
|
79
N/A
|
(10)
N/A
|
5
N/A
|
(24)
N/A
|
(114)
-368%
|
(9)
+92%
|
(30)
-245%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(17)
N/A
|
(26)
-56%
|
(39)
-49%
|
(52)
-33%
|
(54)
-4%
|
(66)
-24%
|
(99)
-49%
|
(117)
-18%
|
(152)
-30%
|
(163)
-7%
|
(167)
-3%
|
(184)
-10%
|
(159)
+14%
|
(160)
0%
|
(131)
+18%
|
(109)
+17%
|
(106)
+3%
|
(88)
+17%
|
|